Advair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100mg/50mg)
Condition:   Asthma Interventions:   Drug: Fluticasone propionate/salmeterol;   Drug: Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder;   Drug: Placebo Sponsor:   West-Ward Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials